Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3 |
| |
Authors: | Li Hanfen Willingham Stephen B Ting Jenny P-Y Re Fabio |
| |
Institution: | Department Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA. |
| |
Abstract: | Alum is the only adjuvant approved for routine use in humans, although the basis for its adjuvanticity remains poorly understood. We have recently shown that alum activates caspase-1 and induces secretion of mature IL-1beta and IL-18. In this study we show that, in human and mouse macrophages, alum-induced secretion of IL-1beta, IL-18, and IL-33 is mediated by the NLR (nucleotide-binding domain leucine-rich repeat-containing) protein NLRP3 and its adaptor ASC, but not by NLRC4. Other particulate adjuvants, such as QuilA and chitosan, induce inflammasome activation in a NLRP3-dependent fashion, suggesting that activation of the NLRP3-inflammasome may be a common mechanism of action of particulate adjuvants. Importantly, we demonstrate that Ag-specific Ab production elicited by vaccines that contain alum is significantly impaired in NLRP3-deficient mice. Our results demonstrate for the first time a role for the NLRP3-inflammasome during development of the immune response elicited by alum-enhanced vaccination and suggest that therapeutic intervention aimed at NLRP3 may improve adjuvant efficacy. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|